Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats.

Nahok K, Li JV, Phetcharaburanin J, Abdul H, Wongkham C, Thanan R, Silsirivanit A, Anutrakulchai S, Selmi C, Cha'on U.

Biomolecules. 2019 Sep 27;9(10). pii: E542. doi: 10.3390/biom9100542.

2.

Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.

Jamnongkan W, Lebrilla CB, Barboza M, Techasen A, Loilome W, Sithithaworn P, Khuntikeo N, Pairojkul C, Chamadol N, Thanan R, Yongvanit P.

Biomolecules. 2019 Sep 27;9(10). pii: E538. doi: 10.3390/biom9100538.

3.

Current omics-based biomarkers for cholangiocarcinoma.

Intuyod K, Armartmuntree N, Jusakul A, Sakonsinsiri C, Thanan R, Pinlaor S.

Expert Rev Mol Diagn. 2019 Oct 1:1-9. doi: 10.1080/14737159.2019.1673162. [Epub ahead of print]

PMID:
31566016
4.

Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.

Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W.

PLoS One. 2019 Aug 19;14(8):e0221024. doi: 10.1371/journal.pone.0221024. eCollection 2019.

5.

Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis.

Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W.

J Proteome Res. 2019 Sep 6;18(9):3305-3316. doi: 10.1021/acs.jproteome.9b00242. Epub 2019 Jul 31.

PMID:
31310545
6.

Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.

Chaiprasert T, Armartmuntree N, Techasen A, Sakonsinsiri C, Pinlaor S, Ungarreevittaya P, Khuntikeo N, Namwat N, Thanan R.

Biomolecules. 2019 Jul 7;9(7). pii: E263. doi: 10.3390/biom9070263.

7.

Designing an Aptasensor Based on Cysteamine-Capped AuNPs for 8-Oxo-dG Detection: A Molecular Dynamics Approach and Experimental Validation.

Toomjeen P, Phanchai W, Choodet C, Chompoosor A, Thanan R, Sakonsinsiri C, Puangmali T.

J Phys Chem B. 2019 Feb 7;123(5):1129-1138. doi: 10.1021/acs.jpcb.8b10436. Epub 2019 Jan 25.

PMID:
30629445
8.

Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation.

Suwannakul N, Ma N, Thanan R, Pinlaor S, Ungarreevittaya P, Midorikawa K, Hiraku Y, Oikawa S, Kawanishi S, Murata M.

Mediators Inflamm. 2018 Oct 9;2018:4867234. doi: 10.1155/2018/4867234. eCollection 2018.

9.

Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.

Wangboon C, Worasith C, Thanan R, Eamudomkarn C, Techasen A, Sithithaworn J, Loilome W, Chamadol N, Pinlaor S, Jumnainsong A, Yongvanit P, Khuntikeo N, Bethony JM, Sithithaworn P.

Acta Trop. 2019 Jan;189:124-128. doi: 10.1016/j.actatropica.2018.10.003. Epub 2018 Oct 12.

PMID:
30321522
10.

The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.

Kaewlert W, Sakonsinsiri C, Namwat N, Sawanyawisuth K, Ungarreevittaya P, Khuntikeo N, Armartmuntree N, Thanan R.

Horm Cancer. 2018 Dec;9(6):408-419. doi: 10.1007/s12672-018-0349-2. Epub 2018 Oct 3.

PMID:
30284180
11.

Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis.

Sakonsinsiri C, Kaewlert W, Armartmuntree N, Thanan R, Pakdeechote P.

Cell Mol Biol (Noisy-le-grand). 2018 Jul 30;64(10):28-33.

PMID:
30084792
12.

Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.

Wangboon C, Yongvanit P, Loilome W, Thanan R, Worasith C, Eamudomkarn C, Chamadol N, Mairiang E, Sithithaworn J, Saichua P, Sripa B, Khuntikeo N, Bethony JM, Sithithaworn P.

Am J Trop Med Hyg. 2018 Jun;98(6):1763-1769. doi: 10.4269/ajtmh.17-0971. Epub 2018 Apr 5.

13.

Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.

Onsurathum S, Haonon O, Pinlaor P, Pairojkul C, Khuntikeo N, Thanan R, Roytrakul S, Pinlaor S.

Tumour Biol. 2018 Apr;40(4):1010428318767195. doi: 10.1177/1010428318767195.

PMID:
29629840
14.

Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine.

Kittirat Y, Techasen A, Thongchot S, Loilome W, Thanan R, Yongvanit P, Sungkhamanon S, Titapun A, Khuntikeo N, Namwat N.

Oncol Lett. 2018 Jan;15(1):347-353. doi: 10.3892/ol.2017.7326. Epub 2017 Nov 1.

15.

Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis.

Jamnongkan W, Thanee M, Yongvanit P, Loilome W, Thanan R, Kimawaha P, Boonmars T, Silakit R, Namwat N, Techasen A.

PeerJ. 2018 Jan 22;6:e4281. doi: 10.7717/peerj.4281. eCollection 2018.

16.

Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.

Armartmuntree N, Murata M, Techasen A, Yongvanit P, Loilome W, Namwat N, Pairojkul C, Sakonsinsiri C, Pinlaor S, Thanan R.

Redox Biol. 2018 Apr;14:637-644. doi: 10.1016/j.redox.2017.11.011. Epub 2017 Nov 13.

17.

Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis.

Phanthaphol N, Techasen A, Loilome W, Thongchot S, Thanan R, Sungkhamanon S, Khuntikeo N, Yongvanit P, Namwat N.

Oncol Lett. 2017 Nov;14(5):5973-5979. doi: 10.3892/ol.2017.6985. Epub 2017 Sep 18.

18.

Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.

Jamnongkan W, Thanan R, Techasen A, Namwat N, Loilome W, Intarawichian P, Titapun A, Yongvanit P.

Tumour Biol. 2017 Jul;39(7):1010428317717655. doi: 10.1177/1010428317717655.

PMID:
28671021
19.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

20.

DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma.

Thanan R, Ma N, Hiraku Y, Iijima K, Koike T, Shimosegawa T, Murata M, Kawanishi S.

Mediators Inflamm. 2016;2016:7937814. doi: 10.1155/2016/7937814. Epub 2016 Mar 10.

21.

Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis.

Thanan R, Techasen A, Hou B, Jamnongkan W, Armartmuntree N, Yongvanit P, Murata M.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):182-8. doi: 10.1016/j.bbrc.2015.06.112. Epub 2015 Jun 20.

PMID:
26100205
22.

Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells.

Thongchot S, Loilome W, Yongvanit P, Dokduang H, Thanan R, Techasen A, Namwat N.

Asian Pac J Cancer Prev. 2015;16(5):2031-5.

23.

Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression.

Khenjanta C, Thanan R, Jusakul A, Techasen A, Jamnongkan W, Namwat N, Loilome W, Pairojkul C, Yongvanit P.

Asian Pac J Cancer Prev. 2014;15(23):10187-92.

24.

Proteomic analysis of kidney in rats chronically exposed to monosodium glutamate.

Sharma A, Wongkham C, Prasongwattana V, Boonnate P, Thanan R, Reungjui S, Cha'on U.

PLoS One. 2014 Dec 31;9(12):e116233. doi: 10.1371/journal.pone.0116233. eCollection 2014.

25.

Oxidative stress and its significant roles in neurodegenerative diseases and cancer.

Thanan R, Oikawa S, Hiraku Y, Ohnishi S, Ma N, Pinlaor S, Yongvanit P, Kawanishi S, Murata M.

Int J Mol Sci. 2014 Dec 24;16(1):193-217. doi: 10.3390/ijms16010193. Review.

26.

BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma.

Duangkumpha K, Techasen A, Loilome W, Namwat N, Thanan R, Khuntikeo N, Yongvanit P.

Tumour Biol. 2014 Oct;35(10):9667-76. doi: 10.1007/s13277-014-2246-9. Epub 2014 Jun 27.

PMID:
24969562
27.

PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.

Jongthawin J, Chusorn P, Techasen A, Loilome W, Boonmars T, Thanan R, Puapairoj A, Khuntikeo N, Tassaneeyakul W, Yongvanit P, Namwat N.

Tumour Biol. 2014 Aug;35(8):8051-64. doi: 10.1007/s13277-014-2021-y. Epub 2014 May 18.

PMID:
24839005
28.

DNA damage in inflammation-related carcinogenesis and cancer stem cells.

Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, Murata M, Kawanishi S.

Oxid Med Cell Longev. 2013;2013:387014. doi: 10.1155/2013/387014. Epub 2013 Dec 5. Review.

29.

Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.

Thanan R, Pairojkul C, Pinlaor S, Khuntikeo N, Wongkham C, Sripa B, Ma N, Vaeteewoottacharn K, Furukawa A, Kobayashi H, Hiraku Y, Oikawa S, Kawanishi S, Yongvanit P, Murata M.

Free Radic Biol Med. 2013 Dec;65:1464-1472. doi: 10.1016/j.freeradbiomed.2013.07.034. Epub 2013 Jul 31.

PMID:
23917144
30.

Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma.

Jamnongkan W, Techasen A, Thanan R, Duenngai K, Sithithaworn P, Mairiang E, Loilome W, Namwat N, Pairojkul C, Yongvanit P.

Tumour Biol. 2013 Apr;34(2):695-704. doi: 10.1007/s13277-012-0597-7. Epub 2012 Nov 28.

PMID:
23188705
31.

Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer.

Thanan R, Murata M, Ma N, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Oikawa S, Kawanishi S.

Mediators Inflamm. 2012;2012:165879. doi: 10.1155/2012/165879. Epub 2012 Apr 10.

32.

Proton pump inhibitors suppress iNOS-dependent DNA damage in Barrett's esophagus by increasing Mn-SOD expression.

Thanan R, Ma N, Iijima K, Abe Y, Koike T, Shimosegawa T, Pinlaor S, Hiraku Y, Oikawa S, Murata M, Kawanishi S.

Biochem Biophys Res Commun. 2012 May 4;421(2):280-5. doi: 10.1016/j.bbrc.2012.03.152. Epub 2012 Apr 6.

PMID:
22503981
33.

Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma.

Thanan R, Oikawa S, Yongvanit P, Hiraku Y, Ma N, Pinlaor S, Pairojkul C, Wongkham C, Sripa B, Khuntikeo N, Kawanishi S, Murata M.

Free Radic Biol Med. 2012 Apr 15;52(8):1465-72. doi: 10.1016/j.freeradbiomed.2012.01.018. Epub 2012 Feb 28.

PMID:
22377619
34.

Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.

Murata M, Thanan R, Ma N, Kawanishi S.

J Biomed Biotechnol. 2012;2012:623019. doi: 10.1155/2012/623019. Epub 2012 Jan 26. Review.

35.

Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen.

Yongvanit P, Thanan R, Pinlaor S, Sithithaworn P, Loilome W, Namwat N, Techasen A, Dechakhamphu S.

Parasitol Res. 2012 May;110(5):1969-77. doi: 10.1007/s00436-011-2725-5. Epub 2011 Dec 9.

PMID:
22160279
36.

Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection.

Ma N, Thanan R, Kobayashi H, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Amro el-K, Oikawa S, Ohnishi S, Murata M, Kawanishi S.

Biochem Biophys Res Commun. 2011 Oct 22;414(2):344-9. doi: 10.1016/j.bbrc.2011.09.073. Epub 2011 Sep 17.

PMID:
21951846
37.

Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis.

Techasen A, Loilome W, Namwat N, Duenngai K, Cha'on U, Thanan R, Sithithaworn P, Miwa M, Yongvanit P.

Parasitol Int. 2012 Mar;61(1):140-4. doi: 10.1016/j.parint.2011.07.004. Epub 2011 Jul 8.

PMID:
21763456
38.

Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.

Thanan R, Murata M, Pinlaor S, Sithithaworn P, Khuntikeo N, Tangkanakul W, Hiraku Y, Oikawa S, Yongvanit P, Kawanishi S.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):518-24. doi: 10.1158/1055-9965.EPI-07-2717.

Supplemental Content

Loading ...
Support Center